The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

If you’re thinking about trying weight loss medication, you probably have a lot of questions about how it works, and how fast ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

However, Eli Lilly is gaining momentum, and expects significant catalysts that could send its stock price soaring in 2025.